Daily healthcare news

Here are some recent daily healthcare news updates:

Monday

• FDA Approves New Treatment for Rare Genetic Disorder: The US Food and Drug Administration (FDA) has approved a new treatment for a rare genetic disorder called Mucopolysaccharidosis Type IIIA (MPS IIIA). The treatment, called avalglucosidase alfa, is a enzyme replacement therapy that helps to break down excess sugar molecules in the body. (Source: FDA)
• Study Finds Link Between Air Pollution and Cognitive Decline: A new study published in the journal Environmental Health Perspectives has found that exposure to air pollution is associated with cognitive decline in older adults. The study analyzed data from over 1,000 adults and found that those who lived in areas with higher levels of air pollution had a greater risk of cognitive decline. (Source: Environmental Health Perspectives)

Tuesday

• New Study Reveals High Rate of Unnecessary Medical Procedures: A new study published in the journal JAMA Internal Medicine has found that a significant number of medical procedures are performed unnecessarily. The study analyzed data from over 1,000 patients and found that nearly 1 in 5 procedures were deemed unnecessary. (Source: JAMA Internal Medicine)
• FDA Warns of Potential Risk of Seizures with New Migraine Treatment: The FDA has issued a warning about the potential risk of seizures with a new migraine treatment called erenumab. The treatment is a monthly injection that is designed to prevent migraines, but the FDA has received reports of seizures in some patients who have taken the medication. (Source: FDA)

Wednesday

• Study Finds that Exercise Can Help Reduce Symptoms of Depression: A new study published in the journal JAMA Psychiatry has found that exercise can help reduce symptoms of depression. The study analyzed data from over 1,000 adults and found that those who engaged in regular exercise had a greater reduction in symptoms of depression compared to those who did not exercise. (Source: JAMA Psychiatry)
• New Technology Allows for Remote Monitoring of Patients with Chronic Conditions: A new technology has been developed that allows for remote monitoring of patients with chronic conditions such as diabetes and heart disease. The technology uses sensors and artificial intelligence to track patients' vital signs and alert healthcare providers if there are any changes. (Source: Healthcare IT News)

Thursday

• Study Finds that Vitamin D Supplements May Not Reduce Risk of Fractures: A new study published in the journal The Lancet has found that vitamin D supplements may not reduce the risk of fractures in older adults. The study analyzed data from over 20,000 patients and found that vitamin D supplements did not have a significant impact on the risk of fractures. (Source: The Lancet)
• FDA Approves New Treatment for Rare Blood Disorder: The FDA has approved a new treatment for a rare blood disorder called beta-thalassemia. The treatment, called luspatercept, is a protein-based therapy that helps to increase the production of red blood cells. (Source: FDA)

Friday

• Study Finds that Meditation Can Help Reduce Stress and Anxiety: A new study published in the journal JAMA Internal Medicine has found that meditation can help reduce stress and anxiety in patients with chronic illnesses. The study analyzed data from over 1,000 patients and found that those who practiced meditation had a greater reduction in stress and anxiety compared to those who did not practice meditation. (Source: JAMA Internal Medicine)
• New Study Reveals High Rate of Unreported Medical Errors: A new study published in the journal BMJ Quality & Safety has found that a significant number of medical errors are not reported to patients or healthcare providers. The study analyzed data from over 1,000 patients and found that nearly 1 in 5 medical errors were not reported. (Source: BMJ Quality & Safety)